Published in Gene Therapy Weekly, November 16th, 2000
The EPI-2010 approach is to prevent asthma symptoms rather than to wait for the patient to suffer symptoms then treat them. EPI-2010 targets the adenosine A1 receptor, which is unique among mediators of asthma in that it is produced in excess in virtually all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.